MATD3 logo

Hospital Mater Dei S.A. Stock Price

BOVESPA:MATD3 Community·R$1.9b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

MATD3 Share Price Performance

R$5.77
1.78 (44.61%)
R$4.50
Fair Value
R$5.77
1.78 (44.61%)
28.2% overvalued intrinsic discount
R$4.50
Fair Value
Price R$5.77
AnalystLowTarget R$4.50
AnalystHighTarget R$7.00
AnalystConsensusTarget R$6.43

MATD3 Community Narratives

AnalystLowTarget·
Fair Value R$4.5 28.2% overvalued intrinsic discount

Rising Labor Costs And Margin Pressures Will Limit Upside Despite Recent Operational Improvements

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystHighTarget·
Fair Value R$7 17.6% undervalued intrinsic discount

High-Complexity Care Expansion Will Drive A Powerful Long-Term Upswing

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value R$6.43 10.2% undervalued intrinsic discount

Complex Care Expansion And Productivity Gains Will Support Long-Term Upside Potential

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
R$6.43
10.2% undervalued intrinsic discount
Revenue
9.17% p.a.
Profit Margin
8.51%
Future PE
14.44x
Price in 2029
R$10.55
R$4.5
28.2% overvalued intrinsic discount
Revenue
7.4% p.a.
Profit Margin
8.44%
Future PE
10.69x
Price in 2028
R$7.6
R$7
17.6% undervalued intrinsic discount
Revenue
11.52% p.a.
Profit Margin
10.52%
Future PE
12.05x
Price in 2028
R$11.95

Trending Discussion

Updated Narratives

MATD3 logo

Complex Care Expansion And Productivity Gains Will Support Long-Term Upside Potential

Fair Value: R$6.43 10.2% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MATD3 logo

Rising Labor Costs And Margin Pressures Will Limit Upside Despite Recent Operational Improvements

Fair Value: R$4.5 28.2% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MATD3 logo

High-Complexity Care Expansion Will Drive A Powerful Long-Term Upswing

Fair Value: R$7 17.6% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Good value with reasonable growth potential.

1 Risk
4 Rewards

Hospital Mater Dei S.A. Key Details

R$2.2b

Revenue

R$1.4b

Cost of Revenue

R$741.3m

Gross Profit

R$629.4m

Other Expenses

R$111.9m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.34
34.08%
5.14%
96.5%
View Full Analysis

About MATD3

Founded
1973
Employees
n/a
CEO
Jose Henrique Salvador
WebsiteView website
www.materdei.com.br

Hospital Mater Dei S.A. operates hospitals in Brazil. The company provides healthcare services, such as hospitalizations, surgeries, oncology, medical consultations, exams, and other services. It also engages in data and artificial intelligence business. The company was incorporated in 1973 and is headquartered in Belo Horizonte, Brazil. Hospital Mater Dei S.A. is a subsidiary of JSS Empreendimentos e Administração LTDA.

Recent MATD3 News & Updates

Analysts Have Made A Financial Statement On Hospital Mater Dei S.A.'s (BVMF:MATD3) Annual Report

Mar 26
Analysts Have Made A Financial Statement On Hospital Mater Dei S.A.'s (BVMF:MATD3) Annual Report

Recent updates

No updates